March 2021 FDA Recall Drug by Akorn, Inc.
D-0301-2021 - Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
This Class II drug recall was voluntarily initiated by Akorn, Inc. on March 8, 2021 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification for unknown impurity observed during 6 month stability testing. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0301-2021
Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
03-08-2021
03-24-2021
8,183 unit dose cups
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Akorn, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide USA
08-09-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07
Batch or Lot Expiration Information
Lot# Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022; Lot 373112, Exp. Date 04/2022